SpyGlass Pharma Inc. (SGP) Stock: Dividends & Earnings

Company Overview:

Market Cap: $874.11M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $17.06 - $32.44

0.7 Year SGP Performance Metrics:

Total Return (with DRIP): 0.4% (0.54% CAGR)

Total Return (no DRIP): 0.4% (0.54% CAGR)

Share Price: 0.4% (0.54% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $10,038

Total Return $ (with DRIP): $38

SGP Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

SGP Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for SGP

Based on past 0.7-year performance, here are SGP growth metrics:

Share price CAGR of +0.54%
Dividend CAGR of +0%

Using SGP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	SGP (DRIP)	SGP - No DRIP
Current Price	$26.50	$26.50
Start Shares	377.36	377.36
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	377.36	377.36
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$26.50	$26.50
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - SGP

NOTE: Above numbers are our estimate based on SGP's Dividend and Price CAGR over past 0.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

SpyGlass Pharma Inc. (SGP) had its IPO on , and is traded on NASDAQ stock exchange.

SpyGlass Pharma Inc. is a biopharmaceutical company focused on drug delivery solutions for chronic eye conditions. The company develops sustained-release ophthalmic products designed to deliver approved medicines in a controlled manner, with an emphasis on treating glaucoma and elevated intraocular pressure. Its lead programs include a drug-pad intraocular lens system intended for use during routine cataract surgery and a non-IOL implant option for patients who are not undergoing cataract surgery. SpyGlass Pharma Inc. works at the intersection of ophthalmology and device-based drug delivery, aiming to improve how long-acting eye treatments are administered in clinical practice. Based in Aliso Viejo, California, the company serves the healthcare and biotechnology markets through products that integrate therapeutic medicine with implantable delivery technology.

SGP website: https://www.spyglasspharma.com